Virologist Dr. Beata Halassy self-treated her recurrent breast cancer by injecting the tumour with viruses she grew in her own lab.
Since her own treatment she has been cancer free for 4 years.
We are looking for a new Trial Statistician/Senior Trial Statistician to join our team. If you're interested in this role or know someone who might be, please see the link below for more details. #ResearchJobs
https://t.co/UcmFppT6Qs
🌟 Exciting News! 🌟 Dr. Alison Tree shares insights on 2-fraction prostate treatment. Catch the latest clinical results from the HERMES trial at the upcoming MR-Linac consortium meeting. Stay tuned! @alison_tree@Xristodouleas@royalmarsdenNHS@ICR_London
Last week, our #MedicalStatistician@BiscombeKatie attended the @NIHRStatistics Conference to presented her poster and rapid-fire talk on methodological challenges in running clinical studies. She also co-ran a breakout session with Liz Hensor from Leeds and Sue Mallett from UCL.
Congratulations to our statistician Katie Biscombe who has received a @NIHRresearch pre-doctoral fellowship. She will be working with @NPortaStat, Prof @EmmaHall71 and Dr Hensor @UniversityLeeds on methodological research of studies that incorporate imaging at their core.
@NIHRresearch@CRUKCamCentre@CUH_NHS@AnnaKirby17@JudithBliss15 PARABLE will investigate if proton beam therapy reduces any long-term effects of treatment without increasing short-term side effects and aims to enrol 192 people in the UK: https://t.co/cHmaFWKvHc
Nice piece by @byFionaMacRae describing the expanding legacy of David Dearnaley @ICR_London@ICR_CTSU We are all standing on the shoulders of giants. Thanks to the JP Moulton foundation too, for funding HERMES. @royalmarsdenNHS
📢 The ICR's and @royalmarsdenNHS' PACE-B trial showed that using advanced radiotherapy called SBRT to deliver precise treatment over a short time frame in #ProstateCancer, didn't lead to worse side effects compared to standard #Radiotherapy 👇
https://t.co/h87xX9zHxR